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Chromatin reorganization and the incorporation of
specific histone modifications during DNA damage
response are essential steps for the successful repair
of any DNA lesion. Here, we show that the histone-
fold protein CHRAC14 plays an essential role in
response to DNA damage in Drosophila. Chrac14
mutants are hypersensitive to genotoxic stress and
do not activate the G2/M cell-cycle checkpoint after
damage induction. Even though the DNA damage
repair process is activated in the absence of
CHRAC14, lesions are not repaired efficiently. In the
absence of CHRAC14, the centromere-specific his-
tone H3 variant CENP-A localizes to sites of DNA
damage, causing ectopic kinetochore formation
and genome instability. CENP-A and CHRAC14 are
able to interact upon damage. Our data suggest
that CHRAC14 modulates chromatin composition in
response to DNA damage, which is required for effi-
cient DNA damage repair in Drosophila.
INTRODUCTION
Chromatin is a highly dynamic structure that is actively remod-
eled during intrinsic changes such as cell cycle or developmental
progression and responds to external cues, such as DNA dam-
age. In response to DNA damage, chromatin-remodeling factors
regulate the access of repair proteins to DNA, participate in
checkpoint signaling, and contribute to the actual DNA repair
process (Kusch et al., 2004; Osley et al., 2007; Soria et al.,
2012). For instance, the noncatalytic subunit of the nucleosome
remodeling complex chromatin accessibility complex (CHRAC),
ACF1, is required for DNA double-stranded break (DSB) repair in
human cells and regulates theG2-M checkpoint (Lan et al., 2010;
Sa´nchez-Molina et al., 2011). Another subunit of CHRAC is the
histone-fold protein CHRAC14 that has subsequently been
found associated with other multisubunit protein complexes
involved in chromatin remodeling and regulation of DNA poly-
merase activity (Corona et al., 2000; Li et al., 2000; Poot et al.,
2000; Suganuma et al., 2008). Within these complexes,CHRAC14 typically forms homo- or heterodimers with other
histone-fold proteins (Eberharter et al., 2001; Hartlepp et al.,
2005; Ito et al., 1997; Kukimoto et al., 2004; Varga-Weisz et al.,
1997).
Chromosome segregation requires specialized centromeric
chromatin structures that are characterized by the presence of
the histone H3 variant CENP-A (also known as CID in Drosophila
melanogaster) (Allshire and Karpen, 2008). The formation and
maintenance of centromeric chromatin is essential for faithful
attachment of spindle microtubules to kinetochores, and loss
of centromere identity leads to aneuploidy and cancer (Kops
et al., 2005). Tight regulation of CENP-A is necessary for chro-
mosome segregation as both overexpression and depletion of
CENP-A are deleterious for cells and organisms (Stellfox et al.,
2013).
Here, we identify CHRAC14 as an essential component of the
Drosophila DNA damage response. Chrac14 mutant flies are
viable and fertile but display developmental defects when
treated with doses of DNA-damaging agents that are tolerated
by wild-type animals. Even though DNA repair processes are
initiated, the lesions remain unrepaired for an extended period
of time. We further found that CHRAC14 and CENP-A interact
and that, in the absence of CHRAC14, CENP-A localizes to
sites of damage, causing severe mitotic defects. We therefore
hypothesize that CHRAC14 prevents inappropriate CENP-A
incorporation at sites of damaged chromatin. Our data show
that CHRAC14 plays a hitherto unappreciated role in DNA repair
at times when the replication-independent assembly of histone
variants prevails.RESULTS AND DISCUSSION
Chrac14Mutant Flies Are Defective in Response of DNA
Damage
Misexpression of CENP-A leads to chromosome segregation
defects and aneuploidy (Blower et al., 2006; Heun et al., 2006).
However, the mechanisms of CENP-A regulation are still only
partially understood.We used a genetic screen to identify factors
that modulate overexpressed CENP-A misincorporation into
chromatin and identified CHRAC14 as one potential candidate
(Figure S1A). CHRAC14 is a subunit of the ATP-dependent
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the large subunit of the complex, ACF1, has been implicated in
G2-M checkpoint activation and repair in human (Lan et al.,
2010; Sa´nchez-Molina et al., 2011). Chrac14 mutant flies are
viable, fertile, and do not show any obvious developmental de-
fects but have not been tested for defects in DNA damage repair.
To analyze a potential function in DNA damage repair, we
exposed third instar larvae from control and Chrac14 mutants
to g irradiation. After irradiation, wild-type flies (Oregon-R)
hatched with no obvious defects except a slight rough eye
phenotype in some flies, whereas Chrac14 mutant flies were
barely able to hatch, and virtually all flies displayed major devel-
opmental defects, including wing deformation and tumor forma-
tions (Figure 1A). Moreover, most irradiatedChrac14mutant flies
were unable to balance their bodies or fly and died within 24 hr of
irradiation treatment (data not shown). This indicates that
Chrac14 mutants are hypersensitive to DNA-damaging agents.
To analyze potential defects in DNA damage response, we
dissected brains from irradiated control and Chrac14 mutant
larvae and used immunofluorescence (IF) for phosphorylated
H2A.X (gH2Av in flies), a well-described modification at sites of
DNAdamage (Rogakou et al., 1998;Madigan et al., 2002).Mitotic
cells were marked with serine 10-phosphorylated histone H3
(pH3) -specific antibodies. Upon damage, control flies showed
drastically reduced numbers of mitotic cells due to G2-M check-
point activation, fromabout 15% inuntreated cells tobelow1% in
irradiated cells. In contrast, about 8% of pH3-positive cells were
still present inChrac14KG01051 flies after damage (Figures 1B and
1C), indicating a failure to arrest damaged cells before entering
mitosis. Additionally, anaphase figures in irradiated Chrac14
mutant tissues suggested that cells do not arrest in G2/M but
actually proceed through mitosis and therefore do not have a
functional G2-M checkpoint (Figure S1B). This conclusion was
substantiated by fluorescence-activated cell sorting analysis of
irradiated larval tissue. Whereas control cells displayed a G2-M
arrest,Chrac14mutant cells showed an almost normal cell-cycle
profilewithonly slightly higherG2-Mcounts andanormal number
of cells inSphase (FigureS1C) after irradiation. Thesecheckpoint
defects of Chrac14 mutants were independent of the altered
CENP-Aoverexpression phenotype thatweobservedgenetically
because overexpression of CENP-A does not interfere with the
G2-M checkpoint after DNA damage (Figure S1D). Our data
thus reveal a function of CHRAC14 in theDNAdamage response.
In contrast to human ACF1 (Sa´nchez-Molina et al., 2011),
Drosophila Acf1 mutant flies maintained a functional G2-MFigure 1. Chrac14 Mutant Flies Are Defective in Response of DNA Dam
(A) Chrac14 mutant and control third instar larvae were treated with g irradiatio
developmental defects, whereas irradiated control flies (Oregon-R) did not show
(B) Chrac14 mutant embryos lack a functional G2-M checkpoint. Images of wh
irradiation treatment (30 Gy) stained for gH2Av (red) to monitor DNA damage, pH3
The inlets on the right show a close up of cells marked in the white square. The
(C) The mitotic index (%) of cells in control (w1118) and Chrac14mutant larval brain
least 1,000 cells analyzed for each brain. ns, not significant.
(D and E) Alkaline comet assay. CHRAC14-depleted cells and control cells were
were monitored by the tail length and quantified by measuring the percentage of D
MMS treatment and immediately (0 hr) and 30 min–4 hr after treatment of control
DNA% from untreated cells and cells up to 4 hr after treatment was measured, an
graph (n = 100 cells per condition).
See also Figure S1.checkpoint (Figure S1E), suggesting a function of CHRAC14 in
G2-Mcheckpoint activation independent of theCHRACcomplex
that may involve alternative interacting partners of CHRAC14
(Iida and Araki, 2004; Suganuma et al., 2008).
To visualize potentially altered DNA damage response or
repair kinetics, we performed a comet assay on control or
CHRAC14-depleted S2 cells that had been treated with methyl-
methane sulfonate (MMS; 0.04%), an effective DNA-damaging
agent (Tercero and Diffley, 2001). Untreated control cells did
not have any significant comet tails. After MMS treatment, a
large tail of DNA fragments was visible that was mostly repaired
within 2 hr (Figures 1D and 1E). Untreated CHRAC14-depleted
cells already displayed a significant comet, indicating that
CHRAC14 depletion alone either causes DNA damage or normal
levels of damage are not repaired efficiently in the absence of
CHRAC14 (Figures 1D and 1E). When we treated CHRAC14-
depleted cells with MMS, we did not only observe a larger comet
indicating more breaks but also found that the repair process
was very ineffective, never reaching completion. S phase, how-
ever, was equally effected by MMS in controls and CHRAC14-
depleted cells (Schwartz, 1989) (Figure S1F). We conclude that
cells lacking CHRAC14 recognize DNA damage, but their
response does not suffice to significantly repair damaged DNA.
CHRAC14 Depletion Causes Ectopic CENP-A
Localization and Chromosome Segregation Defects
To gain insight into the relationship between CHRAC14 and
CENP-A, we analyzed the effects of CHRAC14 depletion or
mutation on endogenous CENP-A in S2 cells and embryos.
Depletion of CHRAC14 in S2 cells led to a significant increase
in CENP-A spots in the nucleus (Figures 2A and 2B). Likewise,
endogenous CENP-A protein levels increased by about 1.8-
fold in CHRAC14 knockdown cells compared to control cells
(Figure 2C). Furthermore, inner and outer kinetochore proteins
colocalized to virtually all CENP-A spots, indicating that ectopic
CENP-A caused kinetochore assembly with inner (CENP-C) and
outer (Spc105) components (Figure 2D). We excluded that aber-
rant genome duplication or an increase in the DNA content
caused this increase of CENP-A foci by analyzing the nuclear
size and cell-cycle profiles of CHRAC14-depleted cells (Figures
S2A and S2B). We extended our analysis to embryo and
assessed endogenous CENP-A in control (w1118) and Chrac14
mutant (Chrac14KG01051) embryos. Increased numbers of
CENP-A spots and changes in chromatin composition wereage
n (30 Gy). After hatching, irradiated Chrac14 mutant flies displayed massive
any developmental defects.
ole third instar larval brain of control (w1118) and Chrac14 mutant flies after g
(green) to mark mitotic cells, and DAPI (blue). The scale bar represents 40 mm.
scale bar represents 20 mm.
s untreated and following irradiation is shown from seven brains ± SEM with at
treated with MMS (0.04%), and the recovery time of the induced DNA breaks
NA within the comet tail (tail DNA%). Representative comet figures for without
and CHRAC14 RNAi cells are shown. The scale bar represents 20 mm. The tail
d the mean values of three independent experiments with SEs are shown in the
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evident in Chrac14 mutant embryos (Figure 2E), recapitulating
our observations in cultured cells.
Next, we prepared mitotic chromosome spreads and per-
formed IF using a-CENP-A and a-HOAP antibodies, the latter
marking telomeres (Cenci et al., 2003). Whereas control cells ex-
hibited properly condensed chromosomes with two bright
CENP-A spots, one on each centromeric region (Figure 2F, up-
per panel, see zoom), spreads from CHRAC14-depleted cells
displayed more than two CENP-A spots (usually four) forming
dicentric chromosomes (17%) or multiple CENP-A spots along
chromosome arms (Figures 2F, lower panel, see zoom, and
S2C). This prominent phenotype of dicentric chromosomes
was only observed on a subset of chromosomes after CHRAC14
RNAi treatment, usually about one or two of any of the chromo-
somes per mitotic spread, but never in control cells. In addition,
13% of CHRAC14-depleted cells also displayed chromosome
breaks (Figure 2F). Interestingly, however, chromosomes or
chromosome fragments did not fuse because a-HOAP staining
was only observed at chromosomes ends. These chromosome
aberrations may consequently lead to defects during mitosis.
Indeed, especially late blastoderm embryos depleted of
CHRAC14 displayed mitotic defects, including anaphase
bridges and lagging chromosomes (Figures 2G, S2D, and
S2E). We conclude that CHRAC14 depletion causes endoge-
nous CENP-A to localize to noncentromeric sites forming
ectopic kinetochores that can cause chromosome segregation
errors.
CHRAC14 Influences CENP-A Localization in Response
to DNA Damage
Studies in Xenopus and mammalian cells showed that CENP-A
is recruited to sites of DNA damage (Zeitlin et al., 2005, 2009).
Additionally, vertebrate-specific histone-fold proteins that
localize to kinetochores are also found at sites of DNA damage
in U2OS cells (Helfricht et al., 2013). We did not observe
CENP-A recruitment to sites of DNA damage caused by lasers,
g irradiation, or treatment with DNA break-inducing drugs in flies
(data not shown). However, because we saw a clear role of
CHRAC14 in DNA damage responses and ectopic localization
of CENP-A in CHRAC14-deficient cells, we hypothesized that
CHRAC14 may function by regulating the histone complement
at DNA damage sites, for instance, by retaining or removing his-Figure 2. CHRAC14 Affects Endogenous CENP-A Distribution and Cau
(A) CHRAC14 depletion increases endogenous CENP-A levels. Representative im
panel) stained for CENP-A (red) and DAPI (blue). The scale bar represents 5 mm.
(B) Single-cell quantification of number of CENP-A spots per nucleus for cells dep
SD with at least 100 cells each. The increase in number of CENP-A spots in CHR
(C) Western blot analysis of CENP-A protein amount in cells depleted of CHRAC1
loading control.
(D) CHRAC14 depletion causes ectopic kinetochore formation. IF of CHRAC14-d
protein CENP-C (red, upper panel) or the outer kinetochore protein Spc105 (red
(E) Chrac14mutant embryos show an elevated CENP-A level. IF of wild-type (w11
scale bar represents 10 mm.
(F) CHRAC14 depletion causes chromosomal abnormalities. IF on mitotic chrom
cells stained for CENP-A (green) and HOAP (red). The scale bar represents 5 mm. In
the percentage of chromosomes in CHRAC14-depleted cells with dicentrics and
(G) CHRAC14-depleted embryos show mitotic defects. Arm-Gal4: dicer-UAS ind
panel) stained for CENP-A (red) and DAPI (blue). The scale bar represents 10 mm
See also Figure S1 and S2.tone variants like CENP-A and gH2Av. We therefore measured
gH2Av and CENP-A protein levels in CHRAC14-depleted cells.
Both gH2Av and CENP-A protein levels increased upon deple-
tion of CHRAC14 in S2 cells (Figure 3A). Misincorporated
CENP-A is proteolytically removed from chromatin to prevent
ectopic centromere formation (Moreno-Moreno et al., 2006,
2011). Inhibition of the proteasome by MG132 led to an increase
of CENP-A in S2 cells independent of the presence of
CHRAC14 (Figure S3A). This indicates that a defect in CENP-A
protein degradation is unlikely to be the cause of ectopic
CENP-A incorporation in the absence of CHRAC14. When we
treated cells stably expressing GFP-CHRAC14 with the DNA
break-inducing drug bleomycin (Burger et al., 1982), we saw
an expected increase in gH2Av levels. Interestingly, the levels
of GFP-CHRAC14 also increased upon bleomycin treatment
(Figure 3B). Conceivably, these increased CHRAC14 levels
may be due to protein stabilization, a notion to be addressed
in the future.
We next tested whether CENP-A is recruited to sites of DNA
damage in CHRAC14-depleted cells after treatment with bleo-
mycin (1 mg/ml) or MMS (0.04%) (Tercero and Diffley, 2001).
CHRAC14-depleted cells showed elevated numbers of gH2Av
and CENP-A foci, but bleomycin or MMS treatment led to a
further increase (Figures 3C, 3D, S3B, and S3C). By quantitative
colocalization analysis (Mander’s coefficient) (Bolte and Corde-
lie`res, 2006) of CENP-A and gH2Av, we found a statistically sig-
nificant increase of CENP-A spots in close proximity to gH2Av
foci in drug-treated CHRAC14-depleted cells (Figure 3E). This
colocalization is not attributable to the increased number of
CENP-A and gH2Av spots, which is accounted for in our statis-
tical analysis. We conclude that, in Drosophila, DNA damage in-
duction alone is not sufficient to recruit detectable amounts of
CENP-A to sites of damage. However, DNA damage coupled
with the loss of CHRAC14 leads to detectable amounts of
CENP-A nearby DNA lesions. Evidently, CHRAC14 may prevent
CENP-A localization at DNA lesions.
CENP-A and CHRAC14 are both histone-fold proteins, sug-
gesting the possibility of a direct interaction. Indeed, both
recombinant proteins can interact in a glutathione S-transferase
(GST) pull-down assay (Figure 3F). The genetic interaction and
mislocalization of CENP-A in CHRAC14-depleted cells may
therefore be caused by a lack of a direct interacting partner ofses Mitotic Defects
ages of S2 cells treated with CHRAC14 RNAi (lower panel) and control (upper
icted in (A). Shown are the mean values from three independent experiments ±
AC14-depleted cells is significant (p < 0.0001 t test).
4, normalized to endogenous CENP-A levels in untreated cells. Actin serves as
epleted and control cells stained for CENP-A (green) and the inner kinetochore
, lower panel), DAPI in blue. The scale bar represents 2 mm.
18) and Chrac14KG01051 embryos stained for CENP-A (red) and DAPI (blue). The
osomes from control (upper panel) and CHRAC14 RNAi-treated (lower panel)
lets on the right show zooms of chromosomesmarkedwith white asterisks and
breaks (n = 68).
uced CHRAC14 RNAi (lower panel) and control arm-GAL4 flies (control; upper
.
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Figure 3. CHRAC14 Influences CENP-A Localization upon DNA Damage Induction
(A) Western blot analysis of control and CHRAC14 RNAi-treated cells. The blot was probed for CENP-A, gH2Av, and actin (loading control).
(B) GFP-CHRAC14 levels increase upon DNA damage induction (numbers are GFP signal intensities where control intensities were normalized to one). Control
(untreated) and bleomycin-treated GFP-CHRAC14 cells were probed for GFP (GFP-CHRAC14 protein levels), gH2Av antibody (DNA damage response), and
tubulin (loading control).
(C) Localization of gH2Av and CENP-A in CHRAC14-depleted cells with and without damage induction. IF images of S2 cells after treatment with the DNA-
damage-inducing drug MMS. The cells were stained for CENP-A (red), gH2Av (green), and DAPI. The scale bar represents 5 mm.
(D) Single-cell quantification of the number of gH2Av foci (left graph) and the number of CENP-A spots (right graph) in the nucleus of cells as depicted in (A) from
three independent experiments ± SD with at least 100 cells analyzed for each condition.
(E) The combination of CHRAC14 RNAi and MMS treatment causes a significant overlap of CENP-A and gH2Av foci. Single-cell quantification of percentage
overlap of CENP-A spots with gH2Av foci in DNA-damage-induced cells by MMS, CHRAC14 RNAi cells, and the combination as indicated and compared
to untreated control cells. Depicted are the mean values from three independent experiments ± SD with at least 25 cells per condition each. The percentage
overlap (Mander’s colocalization coefficient) of CENP-A spots to gH2Av foci was found significantly increased in CHRAC14-depleted cells treated with MMS
(p < 0.005).
(F) In vitro interaction of CHRAC14 and CENP-A. GST-CHRAC14 fusion protein or control GST was bound to glutathione-sepharose and incubated with purified
His-sumo-CENP-A. Bound proteins were resolved by SDS-PAGE and immunoblotted with GST and CENP-A antibodies. Input denotes the starting material. IP,
immunoprecipitation.
(legend continued on next page)
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CENP-A. We prepared protein extracts from CENP-A-GFP em-
bryos and detected an interaction of CHRAC14 and CENP-A in
irradiated CENP-A-GFP embryos (Figures 3G and S3D). This
suggests that the interaction of CHRAC14 and CENP-A occurs
when DNA damage repair pathways are activated. The molecu-
lar context for this previously uncharacterized function of
CHRAC14 is unknown. Among the candidate complexes are
the DNA polymerase epsilonmachinery or ATAC, an acetyltrans-
ferase complex (Iida and Araki, 2004; Suganuma et al., 2008). In
support of this notion, we observed mislocalization of CENP-A
when DNA polymerase epsilon or the ATAC subunit WDS was
depleted in S2 cells (Figures S4A–S4C).
It has been recently suggested that histone-fold proteins can
form nucleosome-like structures at centromeric sites (Nishino
et al., 2012). Our finding of genetic, functional, and physical inter-
actions of CHRAC14 and CENP-A suggest a heterodimer of two
histone-fold proteins that forms only during the DNA damage
response. Our data are consistent with the idea that CHRAC14
prevents CENP-A localization to sites of DNA repair. Whether
this interaction occurs in chromatin or in the form of soluble
dimers remains to be explored.
CENP-A Accumulates at Sites of DNA Damage in the
Absence of CHRAC14
To confirm that CENP-A is recruited to sites of DNA damage, we
depleted the telomere-capping component HIPHOP. This
causes unprotected chromosome ends, which are recognized
as DSBs and repaired by chromosome fusion (Gao et al.,
2010). In cells depleted of HIPHOP alone, 78% of the chromo-
somes were fused by their telomeres as reported previously
(Gao et al., 2010). When we codepleted HIPHOP and CHRAC14,
however, we detected only 22% of fused chromosome ends,
indicating that these unprotected telomeres are not repaired effi-
ciently anymore (Figures 4A and 4B). Importantly, we detected
clear CENP-A accumulation at about 23% of unprotected telo-
meres if both HIPHOP and CHRAC14 were depleted (Figure 4A).
HIPHOP depletion alone did not cause ectopic CENP-A localiza-
tion, presumably because chromosome ends are efficiently re-
paired and fused (Figure 4A). The finding of CENP-A localization
to dysfunctional telomeres in CHRAC14-depleted cells provides
strong support to the earlier notion that CHRAC14 prevents
CENP-A mislocalization at sites of DNA damage. Unprotected
telomeres are repaired by telomere fusion in a Ku70-dependent
nonhomologous end joining (NHEJ) repair mechanism (Celli
et al., 2006). We observe defective double strand repair at
telomeres when CHRAC14 was depleted, suggesting that
CHRAC14 influences NHEJ. This, however, does not exclude
that CHRAC14 is also required for homologous recombination
repair.
Chromatin needs to be restored after repair, and errors in re-
establishing its integrity can be detrimental to the cell (Soria
et al., 2012). Based on our observations, we propose the(G) Coimmunoprecipitation (coIP) of CENP-A-GFP with CHRAC14 after DNA dam
with a final dose of 30 Gy after 1 hr recovery were incubated with GFPtrap. The bo
input (20%). Beads control IP, blocked agarose beads (used as binding control
loaded as a control.
See also Figure S3.following model for the role of CHRAC14 in the DNA damage
response (Figure 4C). Upon repair of DNA lesion, chromatin
integrity needs to be re-established, which involves de novo
nucleosome assembly and the reversal of damage signals on
existing nucleosomes (Soria et al., 2012). Nucleosomes are
formed from the available histone pool, which may lead to
incorporation of histone variants, such as CENP-A. This bears
the risk of ectopic kinetochore formation and requires mecha-
nisms to prevent or correct CENP-A incorporation. Our data
suggest that CHRAC14 plays an important role in preventing
the mistargeting of CENP-A. Why do CENP-A and its orthologs
in other organisms incorporate into sites of damage when it
bears the risk of genome instability? We imagine that the
ectopic incorporation of histone variants rather than canonical
histones at break sites may be of advantage for a cell: histone
variants are incorporated in a replication-independent mecha-
nism and can therefore be used at any time during the cell
cycle (Schuh et al., 2007; Sullivan and Karpen, 2001). Variants
can be distinguished from canonical histones and are targets
for subsequent eviction during later stages of chromatin resto-
ration. Lastly, ectopic incorporation of CENP-A stimulates neo-
centromere formation that may be advantageous from an
evolutionary point of view by ensuring that a centromeric re-
gion resides on every chromosome and chromosome segrega-
tion can take place in the next round of cell division (Burrack
and Berman, 2012).
EXPERIMENTAL PROCEDURES
DNA Damage Assays
Gamma Irradiation on Larvae
Third instar larvae were irradiated with 30 Gy (3,000 rads) of gamma irradia-
tion for 5 min at a dose rate of 6 Gy/min using a GammaCell cesium source fol-
lowed by recovery for 30–60 min at 25C. For dissection and for screening
development defects, the larvae were incubated further at 25C after irradia-
tion until hatching. After recovery, brains were dissected and stained as
described in Supplemental Experimental Procedures. Larval brains were
imaged using the Zeiss LSM 780 confocal microscope. The images were pro-
cessed with ImageJ.
Bleomycin and MMS Treatment
S2 cells were treated with bleomycin (Burger et al., 1982; Morel et al., 2008) for
24 hr or MMS (Nakayama et al., 2006) for 4 hr (day 4 of CHRAC14 RNAi) as
described in Supplemental Experimental Procedures. The cells were recov-
ered for 30–60 min followed by IF (see Supplemental Experimental
Procedures).
Comet Assay
DNA damage recovery times were quantified using alkaline comet assay (Olive
and Bana´th, 2006). After treatment with 0.04% MMS for 4 hr (on day 4 of an
RNAi regime), cells were washed and incubated in fresh serum medium for
the time indicated. At each time point, 105 cells were suspended in PBS and
mixed with 0.7% of low-melting agarose and pipetted onto a slide precoated
with 1% agarose, followed by comet assay using an alkaline electrophoresis
buffer. The percentage of DNA within the comet tail (tail DNA %) calculated
from 100 cells per sample was obtained using an Image J plugin developed
for manual comet analysis (available upon request), and data are shown as
mean values with SEs from three independent experiments.age induction. Protein extracts from CENP-A-GFP embryos with g irradiation
und material was then analyzed by western blot using CHRAC14 antibody. IN,
for the IP reaction). Recombinant GST-CHRAC14 fusion protein as in (F) was
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Figure 4. CENP-A Localizes Specifically to Sites of DNA Damage in CHRAC14-Depleted Cells
(A) CENP-A specifically localizes to unprotected telomeres when CHRAC14 is depleted. Mitotic chromosome spreads of S2 cells depleted for HIPHOP or
HIPHOP and CHRAC14 in combination. White arrows indicate sites of ectopic CENP-A incorporation at chromosome ends in the double-depleted cells.
(legend continued on next page)
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In Vitro Interaction Assay
A direct interaction between CENP-A and CHRAC14 was addressed by add-
ing 4 ml (0.8 mg/ml) of His-sumo-CENP-A to the GST-CHRAC14/bead mixture
(mixed and 10% immediately retracted for input). Fourmicroliters (0.8mg/ml) of
GST-CHRAC14 and 5 ml (0.6 mg/ml) of GST alone (control) were preincubated
for 30 min at 4C with equilibrated glutathione sepharose beads (Amersham
Biosciences). The interaction buffer contained 50 mM Tris (pH 8.0), 150 mM
NaCl, 10% glycerol, 1 mM dithiothreitol, 10% NP-40, and 2 mM phenylmetha-
nesulfonylfluoride. After incubating for 1 hr at 4C, the beads were washed 33
using interaction buffer, then eluted with 10 mM glutathione/50 mM Tris
(pH 8.0), and later analyzed by western blot.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.03.008.
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